Education Management Corp (NASDAQ:EDMC) net profit margin is -20.60% and weekly performance is -9.74%. On last trading day company shares ended up $1.76. Analysts mean target price for the company is $3.88. Education Management Corp (NASDAQ:EDMC) distance from 50-day simple moving average (SMA50) is -37.30%.
On 27 MAY Summer Infant, Inc. (NASDAQ:SUMR) announced that Ken Ward has joined the Company in the newly created role of Senior Vice President, Sales & Operations Planning (S&OP). In this position, Ward will focus on tracking and aligning strategic objectives with financial plans by integrating sales with financial planning, market strategies and new product development. Summer Infant, Inc. (NASDAQ:SUMR) shares fell -5.94% in last trading session and ended the day on $3.01. SMUR Gross Margin is 31.50% and its return on assets is -2.30%. Summer Infant, Inc. (NASDAQ:SUMR) quarterly performance is 64.48%.
On 5 JUNE ENGlobal Corp (NASDAQ:ENG) reported $0.07 earnings per share for the quarter. The company had revenue of $26.90 million for the quarter, compared to the consensus estimate of $49.76 million. ENGlobal Corp (NASDAQ:ENG) shares moved down -7.09% in last trading session and was closed at $3.54, while trading in range of $3.41 – $3.93. ENGlobal Corp (NASDAQ:ENG) year to date (YTD) performance is 152.86%.
On 13 JUNE Corcept Therapeutics Incorporated (NASDAQ:CORT) said it seems exciting for the insiders who have been willing to put their hard-earned money to acquire the shares of the company over the course of this year. Leading the pack of bullish insiders is Director Leonard G. Baker, who recently boosted his stock holding position in the company by more than 100,000 shares. Corcept Therapeutics Incorporated (NASDAQ:CORT) ended the last trading day at $2.28. Company weekly volatility is calculated as 10.08% and price to cash ratio as 5.28. Corcept Therapeutics Incorporated (NASDAQ:CORT) showed a negative weekly performance of -2.15%.
On June 10 Hansen Medical, Inc. (NASDAQ:HNSN) Board of Directors appointed Christopher P. Lowe, a member of its Board of Directors, as its interim Chief Financial Officer, and on such date Peter J. Mariani’s role as our Chief Financial Officer ended. Hansen Medical, Inc. (NASDAQ:HNSN) weekly performance is -6.43%. On last trading day company shares ended up $1.31. Analysts mean target price for the company is $1.88. Hansen Medical, Inc. (NASDAQ:HNSN) distance from 50-day simple moving average (SMA50) is -26.91%.
Leave a Reply